Download PDF
Facial Plast Surg 2020; 36(02): 141-147
DOI: 10.1055/s-0040-1709132
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

High-Risk Nonmelanoma Skin Cancers: Identification, Management, and Reconstruction

Emily S. Misch
1   Department of Otolaryngology—Head and Neck Surgery, University of Colorado, Aurora, Colorado
,
Adam M. Terella
1   Department of Otolaryngology—Head and Neck Surgery, University of Colorado, Aurora, Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
15 May 2020 (online)

    Permissions and Reprints

Abstract

High-risk nonmelanoma skin cancers of the head and neck may be identified through a variety of tumor risk factors, including location on the lips or ears, size > 2 cm, recurrence, patient immunocompromised status, poor tumor differentiation, > 6 mm thickness, Clark level V depth of invasion, and presence of perineural spread. Surgical excision is the mainstay of treatment, with Mohs' micrographic surgery typically preferred to standard surgical excision. When reconstructing these defects, ensuring negative margins is of utmost importance and delaying reconstruction until confirmation of margins is recommended. Attention to the impact of immunosuppression and adjunct radiation therapy on wound healing is important for an optimal cosmetic outcome. As with all high-risk cancer patients, close follow-up and surveillance of these patients is imperative.

Keywords

nonmelanoma skin cancer - squamous cell carcinoma - basal cell carcinoma - high risk - reconstruction
 

  • References

  • 1 Guy Jr GP, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med 2015; 48 (02) 183-187
    CrossrefPubMedGoogle Scholar
  • 2 Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015; 151 (10) 1081-1086
    CrossrefPubMedGoogle Scholar
  • 3 Amin MB, Edge S, Greene F. , et al, eds. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017
    Google Scholar
  • 4 Edge SB, Byrd DR, Compton CC. , et al, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010
    Google Scholar
  • 5 Warner CL, Cockerell CJ. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol 2011; 12 (03) 147-154
    CrossrefPubMedGoogle Scholar
  • 6 Canueto J, Burquillo J, Moyano-Bueno D. , et al. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for the cutaneous squamous cell carcinoma: implications for clinical practice. J Am Acad Dermatol 2019; 80 (01) 106-113
    CrossrefPubMedGoogle Scholar
  • 7 Karia PS, Morgan FC, Califano JA, Schmults CD. Comparison of tumor classifications for cutaneous squamous cell carcinoma of the head and neck in the 7th vs 8th edition of the AJCC cancer staging manual. JAMA Dermatol 2018; 154 (02) 175-181
    CrossrefPubMedGoogle Scholar
  • 8 Jambusaria-Pahlajani A, Kanetsky PA, Karia PS. , et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol 2013; 149 (04) 402-410
    CrossrefPubMedGoogle Scholar
  • 9 Roscher I, Falk RS, Vos L. , et al. Validating 4 staging systems for cutaneous squamous cell carcinoma using population-based data: a nested case-control study. JAMA Dermatol 2018; 154 (04) 428-434
    CrossrefPubMedGoogle Scholar
  • 10 Kim JYS, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P. ; Work Group; Invited Reviewers. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol 2018; 78 (03) 540-559
    CrossrefPubMedGoogle Scholar
  • 11 National Comprehensive Cancer Center. NCCN clinical practice guidelines in oncology; basal cell carcinoma (V1.2020). Available at: www.nccn.org . Accessed December 14, 2019
    PubMedGoogle Scholar
  • 12 Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 2016; 152 (04) 419-428
    CrossrefPubMedGoogle Scholar
  • 13 Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 2006; 32 (11) 1309-1321
    PubMedGoogle Scholar
  • 14 Wermker K, Kluwig J, Schipmann S, Klein M, Schulze HJ, Hallermann C. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear. Eur J Surg Oncol 2015; 41 (01) 128-135
    CrossrefPubMedGoogle Scholar
  • 15 Wang DM, Kraft S, Rohani P. , et al. Association of nodal metastasis and mortality with vermillion vs cutaneous lip location in cutaneous squamous cell carcinoma of the lip. JAMA Dermatol 2018; 154 (06) 701-707
    CrossrefPubMedGoogle Scholar
  • 16 Brantsch KD, Meisner C, Schönfisch B. , et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9 (08) 713-720
    CrossrefPubMedGoogle Scholar
  • 17 Levine HL, Bailin PL. Basal cell carcinoma of the head and neck: identification of the high risk patient. Laryngoscope 1980; 90 (6 Pt 1): 955-961
    CrossrefPubMedGoogle Scholar
  • 18 Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992; 18 (06) 471-476
    CrossrefPubMedGoogle Scholar
  • 19 Morgan FC, Ruiz ES, Karia PS, Besaw RJ, Neel VA, Schmults CD. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter. J Am Acad Dermatol 2019 . doi:10.1016/j.jaad.2019.09.075 (e-pub ahead of print).
    PubMedGoogle Scholar
  • 20 Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26 (06) 976-990
    CrossrefPubMedGoogle Scholar
  • 21 Krediet JT, Beyer M, Lenz K. , et al. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol 2015; 172 (04) 1029-1036
    CrossrefPubMedGoogle Scholar
  • 22 Bøgelund FS, Philipsen PA, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Derm Venereol 2007; 87 (04) 330-334
    CrossrefPubMedGoogle Scholar
  • 23 Mullen JT, Feng L, Xing Y. , et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006; 13 (07) 902-909
    CrossrefPubMedGoogle Scholar
  • 24 Edwards MJ, Hirsch RM, Broadwater JR, Netscher DT, Ames FC. Squamous cell carcinoma arising in previously burned or irradiated skin. Arch Surg 1989; 124 (01) 115-117
    PubMedGoogle Scholar
  • 25 Collins L, Asfour L, Stephany M, Lear JT, Stasko T. Management of non-melanoma skin cancer in transplant recipients. Clin Oncol (R Coll Radiol) 2019; 31 (11) 779-788
    CrossrefPubMedGoogle Scholar
  • 26 Peleva E, Exton LS, Kelley K, Kleyn CE, Mason KJ, Smith CH. Risk of cancer in patients with psoriasis on biological therapies: a systematic review. Br J Dermatol 2018; 178 (01) 103-113
    CrossrefPubMedGoogle Scholar
  • 27 Gupta A, Veness M, De'Ambrosis B, Selva D, Huilgol SC. Management of squamous cell and basal cell carcinomas of the head and neck with perineural invasion. Australas J Dermatol 2016; 57 (01) 3-13
    PubMedGoogle Scholar
  • 28 Carter JB, Johnson MM, Chua TL, Karia PS, Schmults CD. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Dermatol 2013; 149 (01) 35-41
    CrossrefPubMedGoogle Scholar
  • 29 Ross AS, Whalen FM, Elenitsas R, Xu X, Troxel AB, Schmults CD. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg 2009; 35 (12) 1859-1866
    CrossrefPubMedGoogle Scholar
  • 30 Karia PS, Morgan FC, Ruiz ES, Schmults CD. Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: a systematic review and pooled analysis of outcomes data. JAMA Dermatol 2017; 153 (08) 781-788
    CrossrefPubMedGoogle Scholar
  • 31 Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005; 53 (03) 458-463
    CrossrefPubMedGoogle Scholar
  • 32 Cho M, Lee J, James CL, Marshman G, Huilgol SC. Scalp basal cell carcinoma: review of 2,202 cases. Dermatol Surg 2016; 42 (07) 834-841
    CrossrefPubMedGoogle Scholar
  • 33 Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002; 28 (03) 268-273
    PubMedGoogle Scholar
  • 34 Martorell-Calatayud A, Sanmartín Jimenez O, Cruz Mojarrieta J, Guillén Barona C. Cutaneous squamous cell carcinoma: defining the high-risk variant. Actas Dermosifiliogr 2013; 104 (05) 367-379
    CrossrefPubMedGoogle Scholar
  • 35 National Comprehensive Cancer Center. NCCN clinical practice guidelines in oncology; squamous cell carcinoma (V1.2020). Available at: www.nccn.org . Accessed December 10, 2019
    PubMedGoogle Scholar
  • 36 Randle HW. Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg 1996; 22 (03) 255-261
    PubMedGoogle Scholar
  • 37 Haisma MS, Plaat BEC, Bijl HP. , et al. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck. J Am Acad Dermatol 2016; 75 (04) 722-730
    CrossrefPubMedGoogle Scholar
  • 38 Roozeboom MH, Lohman BG, Westers-Attema A. , et al. Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: analysis of a defined population. Acta Derm Venereol 2013; 93 (04) 417-421
    CrossrefPubMedGoogle Scholar
  • 39 Ruiz ES, Karia PS, Morgan FC, Schmults CD. The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management. J Am Acad Dermatol 2017; 76 (02) 217-225
    CrossrefPubMedGoogle Scholar
  • 40 Baum CL, Wright AC, Martinez JC. , et al. A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management. J Am Acad Dermatol 2018; 78 (01) 141-147
    CrossrefPubMedGoogle Scholar
  • 41 Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013; 149 (05) 541-547
    CrossrefPubMedGoogle Scholar
  • 42 Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998; 124 (05) 582-587
    CrossrefPubMedGoogle Scholar
  • 43 Kwon S, Dong ZM, Wu PC. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol 2011; 9: 80
    CrossrefPubMedGoogle Scholar
  • 44 Ahmad FI, Su SY, Gross ND. The role of sentinel lymph node biopsy in the management of cutaneous malignancies. Facial Plast Surg Clin North Am 2019; 27 (01) 119-129
    CrossrefPubMedGoogle Scholar
  • 45 Ahadiat O, Higgins S, Kwon S, Wysong A. Underuse of the sentinel lymph node biopsy for high-risk squamous cell carcinoma of the skin. JAMA Dermatol 2018; 154 (01) 101
    PubMedGoogle Scholar
  • 46 Turner RJ, Leonard N, Malcolm AJ, Lawrence CM, Dahl MG. A retrospective study of outcome of Mohs' micrographic surgery for cutaneous squamous cell carcinoma using formalin fixed sections. Br J Dermatol 2000; 142 (04) 752-757
    CrossrefPubMedGoogle Scholar
  • 47 van Lee CB, Roorda BM, Wakkee M. , et al. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study. Br J Dermatol 2019; 181 (02) 338-343
    CrossrefPubMedGoogle Scholar
  • 48 Rowe DE, Carroll RJ, Day Jr CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15 (03) 315-328
    CrossrefPubMedGoogle Scholar
  • 49 Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992; 27 (2 Pt 1): 241-248
    CrossrefPubMedGoogle Scholar
  • 50 Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 2004; 60 (02) 406-411
    CrossrefPubMedGoogle Scholar
  • 51 Palmer JD, Schneider CJ, Hockstein N. , et al. Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: a propensity score analysis. Oral Oncol 2018; 78: 102-107
    CrossrefPubMedGoogle Scholar
  • 52 Sullivan SR, Scott JR, Cole JK. , et al. Head and neck malignant melanoma: margin status and immediate reconstruction. Ann Plast Surg 2009; 62 (02) 144-148
    CrossrefPubMedGoogle Scholar
  • 53 Bootun R. Effects of immunosuppressive therapy on wound healing. Int Wound J 2013; 10 (01) 98-104
    CrossrefPubMedGoogle Scholar